Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

Source:http://linkedlifedata.com/resource/pubmed/id/16644314

Download in:

View as

General Info

PMID
16644314